EUVIMEDEUVIMED entdecken
Crossref

CNDP2 drives renal tubular fibrosis in diabetic kidney disease via a sulfur-containing amino acids-mTOR signaling axis

Yan Li, Qiao-An Zheng, Yan-Rong Chen, Chang Su, Jia-Yi Luo, Zong-Ji Zheng, Jun-Yu Xue, Zhuo Wang, Yu-Hua Chen, Ping Liu, Zhong-Qiu Guo, Yao-Ming Xue

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2026-10 · 1872 (7) · 168312

DOI: 10.1016/j.bbadis.2026.168312 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2026-10. Verfasst von Yan Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China; Department of Endocrinology and …. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Diabetic Nephropathies, Dipeptidases, Amino Acids. Die Arbeit nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Chinese University of Hong Kong, Shenzhen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Diabetic kidney disease (DKD) is a leading cause of end-stage renal disease, with proximal tubule fibrosis being a key pathological feature. Our previous study identified significant upregulation of cytosolic nonspecific dipeptidase 2 (CNDP2) in the renal tubules of a DKD mouse model, yet its functional role remains unclear. OBJECTIVE This study aimed to investigate the role of CNDP2 in renal tubular fibrosis during DKD, focusing specifically on the "sulfur-containing amino acids (SAAs) metabolism-mammalian target of rapamycin (mTOR)" signaling axis. METHODS We employed integrated in vivo and in vitro models. Kidney- specific Cndp2 knockdown was achieved using an adeno-associated virus vector, and the CNDP2 inhibitor bestatin was used for pharmacological intervention. Renal function, fibrosis, the Ragulator-Rag GTPase-mTOR signaling pathway, amino acid profiles, and ultrastructural changes were assessed. A dietary intervention restricting SAAs was also applied. RESULTS CNDP2 was specifically upregulated in renal tubules under DKD conditions. Both genetic knockdown and pharmacological inhibition of CNDP2 significantly improved renal function and attenuated fibrosis. Mechanistically, CNDP2 hydrolyzes dipeptides, leading to elevated levels of SAAs (cysteine/cystine). This promotes the activation of the Ragulator-Ras-related GTPase (Rag) complex, resulting in subsequent hyperactivation of mTOR signaling and driving tubular fibrosis. Notably, dietary restriction of SAAs similarly ameliorated DKD pathology. CONCLUSION CNDP2 drives renal tubular fibrosis in DKD by activating mTOR signaling through disruption of SAAs metabolism. Our findings reveal a novel "CNDP2-SAAs-mTOR" pathway, identifying CNDP2 as a promising therapeutic target for DKD intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesDiabetic NephropathiesDipeptidasesAmino AcidsKidney TubulesAnimalsSignal TransductionFibrosisMiceMaleHumans

Stichwörter der Autor:innen

Cytosolic nonspecific dipeptidase 2Diabetic kidney diseaseMammalian target of rapamycinSulfur-containing amino acids

Substanzen

TOR Serine-Threonine KinasesDipeptidasesAmino AcidsmTOR protein, mouse

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China; Department of Endocrinology and Metabolism, The Second Affiliated Hospital, School of Medicine, The Ch…
  • Department of Endocrinology and Metabolism, The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, China.
  • Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
  • Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen, 2001 Longxiang Road, Longgang District, Shenzhen, 518172, China.
  • Department of Endocrinology and Metabolism, The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, China. E…
  • Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. Electronic address: yaomingxue@126.com.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province
  • Chinese University of Hong Kong, Shenzhen
  • Chinese University of Hong Kong

Zitieren

APA

Li, Y., Zheng, Q. A., Chen, Y. R., Su, C., Luo, J. Y., Zheng, Z. J., Xue, J. Y., Wang, Z., Chen, Y. H., Liu, P., Guo, Z. Q., & Xue, Y. M. (2026). CNDP2 drives renal tubular fibrosis in diabetic kidney disease via a sulfur-containing amino acids-mTOR signaling axis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1872(7), 168312. https://doi.org/10.1016/j.bbadis.2026.168312

Vancouver

Li Y, Zheng QA, Chen YR, Su C, Luo JY, Zheng ZJ, et al. CNDP2 drives renal tubular fibrosis in diabetic kidney disease via a sulfur-containing amino acids-mTOR signaling axis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2026;1872(7):168312. doi:10.1016/j.bbadis.2026.168312

BibTeX
@article{Li2026,
  author = {Li, Yan and Zheng, Qiao-An and Chen, Yan-Rong and Su, Chang and Luo, Jia-Yi and Zheng, Zong-Ji and Xue, Jun-Yu and Wang, Zhuo and Chen, Yu-Hua and Liu, Ping and Guo, Zhong-Qiu and Xue, Yao-Ming},
  title = {CNDP2 drives renal tubular fibrosis in diabetic kidney disease via a sulfur-containing amino acids-mTOR signaling axis},
  journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
  year = {2026},
  volume = {1872},
  number = {7},
  pages = {168312},
  doi = {10.1016/j.bbadis.2026.168312}
}
Kostenlos starten →